MedTrace Logo

AURORA Study-A Transformative Approach to Support PrEP Medication Persistence

NCT06072443 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2024-06-25

No results posted yet for this study

Summary

This study is designed to test the hypothesis that, compared to oral PrEP, use of CAB-LA in underserved populations in a real-world setting supported by a digital health companion program will be associated with greater medication adherence, persistence, retention-in-care, and improved PROs. Patients in the study will receive current standard care for HIV prevention and be offered enrollment in the digital health companion program.

Goal of the study is to evaluate medication adherence and persistence in patients receiving CAB-LA vs oral PrEP and who engage with a digital health companion program.

Conditions

  • HIV Infections

Interventions

BEHAVIORAL

Digital Health Companion (mobile App)

Participants will complete education modules, health literacy evaluations, and PRO assessments in the Digital Health Companion.

Sponsors & Collaborators

  • ViiV Healthcare

    collaborator INDUSTRY

  • WV Health Right, Inc.

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-30
Primary Completion
2024-12-30
Completion
2025-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06072443 on ClinicalTrials.gov